Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices 15017 

Estimated Total Annual Burden 

Hours: 14,505. 

In compliance with the requirements 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: OPRE Reports Clearance Officer. 

Email address: OPREinfocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on (a) whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Karl Koerper, 

Reports Clearance Officer. 

[FR Doc. 2015–06385 Filed 3–19–15; 8:45 am] 

BILLING CODE 4184–22–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0456] 

Pediatric Stakeholder Meeting; 

Request for Comments; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration is correcting a document 

entitled ‘‘Pediatric Stakeholder Meeting; 

Request for Comments’’ that appeared in 

the Federal Register of February 26, 

2015 (80 FR 10493). The document 

announced a public meeting seeking 

input from patient groups, consumer 

groups, regulated industry, academia 

and other interested parties to obtain 

any recommendations or information 

relevant to the report to Congress that 

FDA is required to submit concerning 

pediatrics, as outlined in the Food and 

Drug Administration Safety and 

Innovation Act (FDASIA). The 

document was published with the 

incorrect docket number. This 

document corrects that error. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Granger, Office of Policy, Planning, 

Legislation, and Analysis, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 32, Rm. 3330, 

Silver Spring, MD 20993, 301–796– 

9115. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of February 26, 2015, 

in FR Doc. 2015–03974, on page 10493, 

the following correction is made: 

On page 10493, in the first column, 

the Docket No. heading, ‘‘[Docket No. 

FDA–20115–N–0456]’’ is corrected to 

read ‘‘[Docket No. FDA–2015–N–0456]’’. 

Dated: March 17, 2015. 

Jill Hartzler Warner, 

Associate Commissioner for Special Medical 

Programs. 

[FR Doc. 2015–06426 Filed 3–19–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIDDK. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE OF DIABETES 

AND DIGESTIVE AND KIDNEY 

DISEASES, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 15–16, 2015. 

Open: April 15, 2015, 8:00 a.m. to 8:15 a.m. 

Agenda: Introductions and Overview. 

Place: National Institutes of Health, 

Building 5, Room 127, 5 Memorial Drive, 

Bethesda, MD 20892. 

Closed: April 15, 2015, 8:15 a.m. to 6:05 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 5, Room 127, 5 Memorial Drive, 

Bethesda, MD 20892. 

Closed: April 16, 2015, 8:00 a.m. to 4:30 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 5, Room 127, 5 Memorial Drive, 

Bethesda, MD 20892. 

Contact Person: Michael W. Krause, Ph.D., 

Scientific Director, National Institute of 

Diabetes and Digestive and Kidney Diseases, 

National Institute of Health, Building 5, 

Room B104, Bethesda, MD 20892–1818, (301) 

402–4633, mwkrause@helix.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 13, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06346 Filed 3–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

mstockstill on DSK4VPTVN1PROD with NOTICES